Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Auto Injectors Market by Product & Data Validation, Analysis and Forecast 2022

Thursday, January 12, 2017 23:41
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors hampering the market. 

Prefilled Syringes in primary drug container segment seems to be predominant in market segment because of the dramatic effect on the way injectable drugs are developed, prescribed and administered. Anaphylaxis in the therapeutic application segment will be dominant throughout the forecast period, as more people are allergic and nauseous. While North America being the largest market, Asia pacific hails as fastest growing because of channeling investments into China and India and improving consumer awareness through marketing campaigns.

 For more information http://www.reportsweb.com/auto-injectors-global-market-outlook-2015-2022

Some of the major key players of the market are Unilife Corporation, Novartis International AG, Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Adamis Pharmaceuticals Corp, Hospira Inc, Scandinavian Health Limited (SHL) Group, Sanofi SA, Itelliject Inc , Pfizer, Inc., Lincoln Medical Ltd, Ypsomed Holdings AG, ALK Abello, Teva Pharmaceuticals Ltd and Biogen Idec, Inc. 

Devices Covered:
-Smart Autoinjectors 
-Product Specific Autoinjectors 
-Manual Injection Autoinjectors 
-Disposable Autoinjectors 
-Reusable Autoinjectors 
-Variable Dose Autoinjectors 
-Automated Injection Autoinjectors 
Product Types Covered:
-Standardized Auto-injectors 
-Customized Auto-injectors
Therapeutic Applications covered: 
-Autoimmune Diseases 
-Anaphylaxis 
-Anticoagulants 
-Neurology 
-Rheumatoid Arthritis 
-Infectious Diseases 
-Reproductive Health 
-Hormones 
-Hematopoietics 
-Multiple Sclerosis 
-Emergency Medicine 
-Other Therapeutic Application
Primary Drug Containers Covered: 
-Cartridges 
-Single Chamber Cartridge 
-Dual Chamber Cartridge 
-Vials 
-Prefilled Syringes 
-Plastic Prefilled Syringes 
-Glass Prefilled Syringes 
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK 
-Spain 
-Rest of Europe 
-Asia Pacific
-Japan 
-China 
-India 
-Australia 
-New Zealand 
-Rest of Asia Pacific 
- Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322797/sample

11 Company Profiling 
11.1 Unilife Corporation 
11.2 Novartis International AG 
11.3 Becton, Dickinson and Company 
11.4 Antares Pharma, Inc., 
11.5 Mylan, Inc. 
11.6 Adamis Pharmaceuticals Corp 
11.7 Hospira Inc 
11.8 Scandinavian Health Limited (SHL) Group 
11.9 Sanofi SA 
11.10 Itelliject Inc 
11.11 Pfizer, Inc. 
11.12 Lincoln Medical Ltd 
11.13 Ypsomed Holdings AG 
11.14 ALK Abello 
11.15 Teva Pharmaceuticals Ltd 
11.16 Biogen Idec, Inc. 

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322797/buying

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.